Abstract: Novel 3-N-cycloalkyl-5-substituted-2-thioxothiazolidin-4-one derivatives that are effective for use in treating viral infections are described. Also described are pharmaceutical compositions comprising the 3-N-cycloalkyl-5-substituted-2-thioxothiazolidin-4-one derivatives and methods for using the compounds or compositions.
Type:
Grant
Filed:
June 17, 2011
Date of Patent:
January 13, 2015
Assignees:
FUZIANS BIOMEDICALS, Inc., The UAB Research Foundation
Abstract: Novel 3-N-cycloalkyl-5-substituted-2-thioxothiazolidin-4-one derivatives that are effective for use in treating viral infections are described. Also described are pharmaceutical compositions comprising the 3-N-cycloalkyl-5-substituted-2-thioxothiazolidin-4-one derivatives and methods for using the compounds or compositions.
Type:
Application
Filed:
June 17, 2011
Publication date:
April 11, 2013
Applicants:
THE UAB RESEARCH FOUNDATION, FUZIANS BIOMEDICALS, INC.